108 related articles for article (PubMed ID: 2440550)
1. Folate and methotrexate polyglutamate tissue levels in rhesus monkeys following chronic low-dose methotrexate.
Winick NJ; Kamen BA; Balis FM; Holcenberg J; Lester CM; Poplack DG
Cancer Drug Deliv; 1987; 4(1):25-31. PubMed ID: 2440550
[TBL] [Abstract][Full Text] [Related]
2. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
[TBL] [Abstract][Full Text] [Related]
3. Analysis of methotrexate polyglutamate derivatives in vivo.
Kamen BA; Winick N
Methods Enzymol; 1986; 122():339-46. PubMed ID: 2422524
[No Abstract] [Full Text] [Related]
4. Methotrexate (MTX) concentration in tumors following low-dose MTX.
Winick NJ; Kamen BA; Streckfuss A; Craig J; McGuirt F; Capizzi RL; Sklar F; Coln D
Cancer Chemother Pharmacol; 1987; 20(1):78-80. PubMed ID: 2441884
[TBL] [Abstract][Full Text] [Related]
5. Detection by high-performance liquid chromatography of methotrexate and its metabolites in tumor tissue from osteosarcoma patients treated with high-dose methotrexate/leucovorin rescue.
Samuels LL; Feinberg A; Moccio DM; Sirotnak FM; Rosen G
Biochem Pharmacol; 1984 Sep; 33(17):2711-4. PubMed ID: 6205660
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate and its polyglutamate derivatives in erythrocytes during and after weekly low-dose oral methotrexate therapy of children with acute lymphoblastic leukemia.
Schrøder H; Fogh K
Cancer Chemother Pharmacol; 1988; 21(2):145-9. PubMed ID: 2450690
[TBL] [Abstract][Full Text] [Related]
7. Reduced folate carrier expression in acute lymphoblastic leukemia: a mechanism for ploidy but not lineage differences in methotrexate accumulation.
Belkov VM; Krynetski EY; Schuetz JD; Yanishevski Y; Masson E; Mathew S; Raimondi S; Pui CH; Relling MV; Evans WE
Blood; 1999 Mar; 93(5):1643-50. PubMed ID: 10029593
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates.
Kremer JM; Galivan J; Streckfuss A; Kamen B
Arthritis Rheum; 1986 Jul; 29(7):832-5. PubMed ID: 2427090
[TBL] [Abstract][Full Text] [Related]
9. Lack of an effect of breast cancer resistance protein (BCRP/ABCG2) overexpression on methotrexate polyglutamate export and folate accumulation in a human breast cancer cell line.
Rhee MS; Schneider E
Biochem Pharmacol; 2005 Jan; 69(1):123-32. PubMed ID: 15588721
[TBL] [Abstract][Full Text] [Related]
10. Formation of methotrexate polyglutamates in rat hepatocytes.
Gewirtz DA; White JC; Randolph JK; Goldman ID
Cancer Res; 1979 Aug; 39(8):2914-8. PubMed ID: 455278
[TBL] [Abstract][Full Text] [Related]
11. Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia.
Synold TW; Relling MV; Boyett JM; Rivera GK; Sandlund JT; Mahmoud H; Crist WM; Pui CH; Evans WE
J Clin Invest; 1994 Nov; 94(5):1996-2001. PubMed ID: 7525652
[TBL] [Abstract][Full Text] [Related]
12. Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis.
Mauritz R; Peters GJ; Priest DG; Assaraf YG; Drori S; Kathmann I; Noordhuis P; Bunni MA; Rosowsky A; Schornagel JH; Pinedo HM; Jansen G
Biochem Pharmacol; 2002 Jan; 63(2):105-15. PubMed ID: 11841783
[TBL] [Abstract][Full Text] [Related]
13. Role of methotrexate polyglutamates in methotrexate- and sequential methotrexate-5-fluorouracil-mediated cell kill.
McGuire JJ; Mini E; Hsieh P; Bertino JR
Cancer Res; 1985 Dec; 45(12 Pt 1):6395-400. PubMed ID: 2415244
[TBL] [Abstract][Full Text] [Related]
14. Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formation.
Jolivet J; Cole DE; Holcenberg JS; Poplack DG
Cancer Res; 1985 Jan; 45(1):217-20. PubMed ID: 2578094
[TBL] [Abstract][Full Text] [Related]
15. In situ methotrexate polyglutamate formation in rat tissues.
Krakower GR; Kamen BA
J Pharmacol Exp Ther; 1983 Dec; 227(3):633-8. PubMed ID: 6197519
[TBL] [Abstract][Full Text] [Related]
16. Regulation of methotrexate polyglutaminate formation in Ehrlich ascites carcinoma cells by endogenous folate pool.
Balińska M
Acta Biochim Pol; 1986; 33(1):31-7. PubMed ID: 2424199
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate disposition, anti-folate activity and efficacy in the collagen-induced arthritis mouse model.
Singh RK; van Haandel L; Kiptoo P; Becker ML; Siahaan TJ; Funk RS
Eur J Pharmacol; 2019 Jun; 853():264-274. PubMed ID: 30951714
[TBL] [Abstract][Full Text] [Related]
18. Measurement of erythrocyte methotrexate polyglutamate levels: ready for clinical use in rheumatoid arthritis?
Danila MI; Hughes LB; Brown EE; Morgan SL; Baggott JE; Arnett DK; Bridges SL
Curr Rheumatol Rep; 2010 Oct; 12(5):342-7. PubMed ID: 20665136
[TBL] [Abstract][Full Text] [Related]
19. Rescue effect of exogenous reduced folates on methotrexate polyglutamylation and dihydrofolate reductase activity in L1210 cells.
Balińska M
Acta Biochim Pol; 1988; 35(3):199-205. PubMed ID: 2469275
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy.
Stamp LK; O'Donnell JL; Chapman PT; Zhang M; James J; Frampton C; Barclay ML
Arthritis Rheum; 2010 Feb; 62(2):359-68. PubMed ID: 20112376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
